Comparison of Effects and Complications of Different Anticoagulants Used after Arthroscopic Knee Surgery under the Concept of Enhanced Recovery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800017265

Enrollment

Unknown

Registered

2018-07-20

Start date

2018-08-01

Completion date

Unknown

Last updated

2018-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroscopic Knee Surgery

Interventions

Experimental group:Rivaroxaban

control group:Enoxaparin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 74 years; 2. arthroscopic Knee Surgery; 3. Patients with moderate risk of VTE score and above.

Exclusion criteria

Exclusion criteria: Complications: fracture; high risk of hemorrhage; history of cardiovascular disease or cardiovascular disease; VTE history or occurrence of VTE; Hematological disease; active digestive tract ulcer or organ injury with bleeding tendency; liver and kidney insufficiency; Haemorrhagic stroke occurred recently; any cause could not be combined with research,such as speech comprehension disorder, telephone communication disorder, central nervous system disease; pregnancy.

Design outcomes

Primary

Measure	Time frame
incidence of VTE;mortality;incidence of bleeding;incidence of drug related adverse reactions;average hospitalization;	—

Secondary

Measure	Time frame
Knee motion function after six months;Quality of life;Anticoagulant cost;	—

Countries

China

Contacts

Public ContactLi Peng-Cheng

West China Hospital, Sichuan University

16699411@qq.com+86 18980601911

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026